Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome
- Authors: Dralova OV1, Maximov ML1, Ermolaeva AS1
-
Affiliations:
- I.M. Sechenov MMA
- Issue: No 4 (2010)
- Pages: 206-208
- Section: Articles
- URL: https://journals.rcsi.science/2313-0245/article/view/337473
- ID: 337473
Cite item
Abstract
The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and obesity. The antihypertensive efficacy of aliskiren in combination with valsartan was demonstrated as dose-dependent, and was well tolerated and high safety of this combination therapy.
About the authors
O V Dralova
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
M L Maximov
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
A S Ermolaeva
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
Supplementary files
